mvvp banner red border
Home The Team Portfolio Limited Partners Co-InvestorsNews ArticlesContact Us

MVVP logo



IngleWood and Mesa Verde Co-Investment Partners

Audax Ventures HBM OrbiMed
BioFrontier Partners* HCMH Ventures* Oxford Bioscience Ventures
BioVeda IBM Pacific Growth
BioVentures Investors IDEO Perseus-Soros
Burrill & Company Imperial Bank Prarie Gold Ventures
Canaan Partners
In-Q-Tel Prism Ventures
Care Capital
Cottonwood Technology
J&J Development Corporation*RBC
CDIBJF Shea & Co* RCT BioVentures*
CMEA Kingsbury Associates Rivervest
Cross Atlantic Life Science Partners* Sanderling*
Domain Associates* Lilly BioVentures Sofinov*
Dresdner Kleinwort Lombard Odier & Cie SR One
Epic Ventures
Merrill Lynch (KECALP) TPG Biotech
Euclid SR Partners Mitsui & Co Trian Equities
Forward Ventures Morningside Tullis Health Investors
Foundation Medical Partners Moss Forest Ventures Utah Ventures
GeneChem Novartis* Vector Fund Management
GIMV Novo A/S vSpring Capital
Hambrecht & Quist
Enter Rh Capital LLC. Along omega replica with its dismal fiscal fourth quarter release, Elizabeth Arden announced yesterday rolex replica that Rh was purchasing $50 million of preferred stock with a 5% coupon and will hublot replica receive warrants to purchase 2.5 million common cartier replica shares at $20.39 each, which would represent about 7.6% of the company's shares outstanding louis vuitton replica. The deal envisions Rh stake going as omega replica high as 30%, at which point a standstill agreement kicks in.

*Denotes round IngleWood led
Denotes multi-deal partners